Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vollmar

Showing results (151-160 of 240) with videos related to

Pageof 24
Sort By:
Oncogene|January 30, 2003
Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERKDorothee S M Antlsperger, Verena M Dirsch, Dulce Ferreira, et al.
Journal of Molecular and Cellular Cardiology|July 21, 2012
The vascular barrier-protecting hawthorn extract WS® 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathwayElisabeth A Willer, Roland Malli, Alexander I Bondarenko, et al.
Journal of Natural Products|September 18, 2009
Antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injuryAndreas Hartkorn, Florian Hoffmann, Hussam Ajamieh, et al.
Biochemical Pharmacology|June 15, 2011
Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generationRuth Hoffmann, Karin von Schwarzenberg, Nancy López-Antón, et al.
Molecular Cancer Therapeutics|August 5, 2017
Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMTHenriette Merk, Philipp Messer, Maximilian A Ardelt, et al.
International Journal of Cancer|October 30, 2013
V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivoRebekka Kubisch, Thomas Fröhlich, Georg J Arnold, et al.
Circulation Research|December 1, 2004
Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activationRobert Fürst, Corinna Brueckl, Wolfgang M Kuebler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2008
Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesisAndrea S Rothmeier, Ivan Ischenko, Jos Joore, et al.
British Journal of Pharmacology|July 9, 2016
Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffoldS Zhang, M Ulrich, A Gromnicka, et al.
Plos One|May 23, 2012
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapyJennifer Herrmann, Yasser A Elnakady, Romina M Wiedmann, et al.
Pageof 24

Showing results (151-160 of 240) with videos related to

Sort By:
Pageof 24
Oncogene|January 30, 2003
Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERKDorothee S M Antlsperger, Verena M Dirsch, Dulce Ferreira, et al.
Journal of Molecular and Cellular Cardiology|July 21, 2012
The vascular barrier-protecting hawthorn extract WS® 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathwayElisabeth A Willer, Roland Malli, Alexander I Bondarenko, et al.
Journal of Natural Products|September 18, 2009
Antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injuryAndreas Hartkorn, Florian Hoffmann, Hussam Ajamieh, et al.
Biochemical Pharmacology|June 15, 2011
Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generationRuth Hoffmann, Karin von Schwarzenberg, Nancy López-Antón, et al.
Molecular Cancer Therapeutics|August 5, 2017
Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMTHenriette Merk, Philipp Messer, Maximilian A Ardelt, et al.
International Journal of Cancer|October 30, 2013
V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivoRebekka Kubisch, Thomas Fröhlich, Georg J Arnold, et al.
Circulation Research|December 1, 2004
Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activationRobert Fürst, Corinna Brueckl, Wolfgang M Kuebler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 6, 2008
Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesisAndrea S Rothmeier, Ivan Ischenko, Jos Joore, et al.
British Journal of Pharmacology|July 9, 2016
Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffoldS Zhang, M Ulrich, A Gromnicka, et al.
Plos One|May 23, 2012
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapyJennifer Herrmann, Yasser A Elnakady, Romina M Wiedmann, et al.
Pageof 24